Literature DB >> 3102352

Human T lymphocytes stimulated by phytohaemagglutinin undergo a single round of cell division without a requirement for interleukin-2 or accessory cells.

A R Mire-Sluis, R G Wickremasinghe, A V Hoffbrand, A M Timms, G E Francis.   

Abstract

Monocyte-depleted human T lymphocytes completed a single round of DNA synthesis and cell division when treated with phytohaemagglutinin (PHA). Direct assay of culture supernatants showed that very low amounts of interleukin-2 (IL-2) were synthesized in these cultures. Furthermore, the first round of cell division was totally unaffected by the addition of saturating amounts of anti-Tac, a monoclonal antibody against the IL-2 receptor. These data strongly suggest that stimulation of IL-2 receptors by IL-2 was not required for the completion of the first round of mitosis. By contrast, proliferation of the daughter cells produced by the first cell doubling required the addition of exogenous IL-2 and was totally abolished by anti-Tac. These results were confirmed by experiments using single lymphocytes, which also showed that accessory cells were not required during the first cell doubling of PHA-stimulated lymphocytes. We therefore propose a modified model for in vitro T-lymphocyte activation, wherein PHA stimulate a single round of cell proliferation without a requirement for stimulation by IL-2. The resulting daughter cells now require IL-2 for further proliferation. By analogy, we suggest that triggering by antigen in vivo (in the context of products of the major histocompatibility locus) may also stimulate a single round of IL-2-independent division in appropriate clones of T lymphocytes, with the resulting population of daughter cells requiring IL-2 for further expansion of the population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102352      PMCID: PMC1453360     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 4.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 5.  Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins.

Authors:  R Palacios
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

7.  T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.

Authors:  G Janossy; H G Prentice; J P Grob; K Ivory; N Tidman; J Grundy; M Favrot; M K Brenner; D Campana; H A Blacklock
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 8.  Interleukin 2: biology and biochemistry.

Authors:  S Gillis
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

9.  Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.

Authors:  J M Depper; W J Leonard; R J Robb; T A Waldmann; W C Greene
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.

Authors:  L M Neckers; J Cossman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  6 in total

1.  Identification of an additional two-cysteine containing type I interferon in rainbow trout Oncorhynchus mykiss provides evidence of a major gene duplication event within this gene family in teleosts.

Authors:  Mingxian Chang; Pin Nie; Bertrand Collet; Christopher J Secombes; Jun Zou
Journal:  Immunogenetics       Date:  2009-03-14       Impact factor: 2.846

2.  Functional heterogeneity in the process of T lymphocyte activation; barium blocks several modes of T cell activation, but spares a functionally unique subset of PHA-activable T cells.

Authors:  L T Peçanha; G A Dos Reis
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Authors:  Helga Simon-Molas; Claudia Arnedo-Pac; Pere Fontova; Anna Vidal-Alabró; Esther Castaño; Ana Rodríguez-García; Àurea Navarro-Sabaté; Núria Lloberas; Anna Manzano; Ramon Bartrons
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

4.  Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.

Authors:  J Richner; E P Ambinder; K Hoffmann; E J Feuer; G Bekesi
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Differential Leukocyte MicroRNA Responses Following Pan T Cell, Allorecognition and Allosecretome-Based Therapeutic Activation.

Authors:  Xining Yang; Wendy M Toyofuku; Mark D Scott
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-10-22       Impact factor: 4.291

6.  Network between Cytokines, Cortisol and Occupational Stress in Gas and Oilfield Workers.

Authors:  Marcella Reale; Erica Costantini; Chiara D'Angelo; Luca Coppeta; Rocco Mangifesta; Srinivas Jagarlapoodi; Marta Di Nicola; Luca Di Giampaolo
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.